Home » Overbrook to Distribute Phytronix Ionization Technology

Overbrook to Distribute Phytronix Ionization Technology

May 01, 2009

NEW YORK (GenomeWeb News) – Overbrook Scientific will distribute Phytronix's laser diode thermal desorption ionization technology to labs in the US, under an agreement announced today.

According to Boston-based Overbrook, the LDTD technology can increase the speed of analyzing compounds 20 to 100 times compared to established techniques based on liquid chromatography with mass spectrometry. The technology can be added to any LC-MS/MS system, said Overbrook, which also claims that the technology offers a better price and performance over APCI and MALDI techniques.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Scan

Best Options

The Seattle Times writes that pharmacogenomics testing can help choose medications that may work best for people with depression.

A Butterfly's Wings

Researchers report that deleting one gene from butterflies affects their wing coloration patterns, according to the Washington Post.

This Week in PNAS

In PNAS this week: genome sequencing of weevil symbionts, retinoid X receptor deletion in lung cancer metastasis, and more.

Pathogen Tracking

Sequencing could help combat foodborne illnesses, according to a blog post by Food and Drug Administration officials.

Oct
10
Featured Webinar

GenomeWeb/ABRF 2017 Webinar Series: Ask the Experts: Ensuring High-Quality Proteomic Studies with Core Lab Resources

Sponsored by
PerkinElmer

This online, interactive seminar will answer researchers’ most pressing questions about how to gain outstanding research results from proteomic studies.

What's Popular?

In Proteomics & Protein Research

  1. MSK Researchers Develop High-Sensitivity Mass Spec Assay for Clinical Cancer Work

    Premium

  2. NSGC Panelists Discuss Strategies to Convert Variants of Unknown Significance to Known Significance

  3. Early Results From Second Side-Out Study Indicate Benefits of Molecularly Guided Cancer Treatment

    Premium

  4. Biognosys, Waters Ink Comarketing Deal for DIA Mass Spec Tech

  5. HMS Team Uses Protein Coregulation Analysis to Build Cancer Interactome, Predict Therapy Response

    Premium

Sponsorships

Privacy Policy.  Copyright © 2017 GenomeWeb LLC.  All Rights Reserved.